Neos Therapeutics Reports Second Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall St mixed as Middle East tensions eclipse tech strength
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Neos Therapeutics (NEOS) Reports In-Line Q2 EPS
August 8, 2017 7:18 AM EDTNeos Therapeutics (NASDAQ: NEOS) reported Q2 EPS of ($0.83), in-line with the analyst estimate of ($0.83). Revenue for the quarter came in at $4.9 million versus the consensus estimate of $5.67 million.
For earnings history and earnings-related data on Neos Therapeutics (NEOS) click here.
... More